BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33006296)

  • 21. Left ventricular deformation and myocardial fibrosis in pediatric patients with Duchenne muscular dystrophy.
    Kerstens TP; van Everdingen WM; Habets J; van Dijk APJ; Helbing WA; Thijssen DHJ; Udink Ten Cate FEA
    Int J Cardiol; 2023 Oct; 388():131162. PubMed ID: 37433407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
    Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
    Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Left Ventricular Involvement Detected by Cardiovascular Magnetic Resonance Feature Tracking in Arrhythmogenic Right Ventricular Cardiomyopathy: The Effects of Left Ventricular Late Gadolinium Enhancement and Right Ventricular Dysfunction.
    Chen X; Li L; Cheng H; Song Y; Ji K; Chen L; Han T; Lu M; Zhao S
    J Am Heart Assoc; 2019 Sep; 8(17):e012989. PubMed ID: 31441357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of Myocardial Contrast-Enhanced T
    Höke U; Khidir MJ; van der Geest RJ; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 May; 119(9):1456-1462. PubMed ID: 28274575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.
    Schwarz K; Ahearn T; Srinivasan J; Neil CJ; Scally C; Rudd A; Jagpal B; Frenneaux MP; Pislaru C; Horowitz JD; Dawson DK
    J Am Soc Echocardiogr; 2017 Aug; 30(8):745-755. PubMed ID: 28599831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.
    Disertori M; Rigoni M; Pace N; Casolo G; Masè M; Gonzini L; Lucci D; Nollo G; Ravelli F
    JACC Cardiovasc Imaging; 2016 Sep; 9(9):1046-1055. PubMed ID: 27450871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.
    Florian A; Ludwig A; Stubbe-Dräger B; Boentert M; Young P; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
    J Cardiovasc Magn Reson; 2015 May; 17(1):40. PubMed ID: 26001801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement.
    Halliday BP; Baksi AJ; Gulati A; Ali A; Newsome S; Izgi C; Arzanauskaite M; Lota A; Tayal U; Vassiliou VS; Gregson J; Alpendurada F; Frenneaux MP; Cook SA; Cleland JGF; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1645-1655. PubMed ID: 30219397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging.
    Te Rijdt WP; Ten Sande JN; Gorter TM; van der Zwaag PA; van Rijsingen IA; Boekholdt SM; van Tintelen JP; van Haelst PL; Planken RN; de Boer RA; Suurmeijer AJH; van Veldhuisen DJ; Wilde AAM; Willems TP; van Dessel PFHM; van den Berg MP
    Eur Heart J Cardiovasc Imaging; 2019 Jan; 20(1):92-100. PubMed ID: 29635323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early marker of regional left ventricular deformation in patients with hypertrophic cardiomyopathy evaluated by MRI tissue tracking: The effects of myocardial hypertrophy and fibrosis.
    Xu HY; Chen J; Yang ZG; Li R; Shi K; Zhang Q; Liu X; Xie LJ; Jiang L; Guo YK
    J Magn Reson Imaging; 2017 Nov; 46(5):1368-1376. PubMed ID: 28370909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.
    Rosales XQ; Moser SJ; Tran T; McCarthy B; Dunn N; Habib P; Simonetti OP; Mendell JR; Raman SV
    J Cardiovasc Magn Reson; 2011 Aug; 13(1):39. PubMed ID: 21816046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.